You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

chemotherapy

Showing 51 - 75 of 424
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Rectal Adenocarcinoma, Stage II Rectal Cancer AJCC v8, Stage IIA Rectal Cancer AJCC v8 Trial in Houston (drug, other, procedure)

Not yet recruiting
  • Rectal Adenocarcinoma
  • +8 more
  • Chemotherapy
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Feb 25, 2022

Ovarian Cancer Trial in Wuhan (KM1, Chemotherapy)

Not yet recruiting
  • Ovarian Cancer
  • KM1
  • Chemotherapy
  • Wuhan, Hubei, China
    Tongji Hospital of Tongji Medical College, Huazhong University o
Jan 5, 2023

Colorectal Adenocarcinoma, Colorectal Carcinoma Metastatic in the Lung, Stage IV Colorectal Cancer AJCC v8 Trial in Canada,

Recruiting
  • Colorectal Adenocarcinoma
  • +5 more
  • Chemotherapy
  • Metastasectomy
  • Boston, Massachusetts
  • +7 more
Apr 19, 2022

Pancreatic Cancer Trial in New York (Chemotherapy, Endoscopic Ultrasound-Guided Radiofrequency Ablation (EUS-RFA))

Not yet recruiting
  • Pancreatic Cancer
  • Chemotherapy
  • Endoscopic Ultrasound-Guided Radiofrequency Ablation (EUS-RFA)
  • New York, New York
    Tisch Hospital
Feb 9, 2023

Solid Tumor, Adult Trial in Belgium, United Kingdom, United States (EOS100850, Pembrolizumab, Chemotherapy)

Recruiting
  • Solid Tumor, Adult
  • Hackensack, New Jersey
  • +4 more
Jun 27, 2022

Solid Tumors, Lymphoma Trial in Valhalla, Charlotte, Houston (Eflapegrastim, Chemotherapy)

Recruiting
  • Solid Tumors
  • Lymphoma
  • Valhalla, New York
  • +3 more
Feb 28, 2022

Molecular Analysis and Treatment Options of SCLC

Recruiting
  • Small-cell Lung Cancer
  • +4 more
  • Chemotherapy
  • Shanghai, China
    Shanghai Chest Hospital
Jul 6, 2023

ALK Fusion Protein Expression, Adjuvant Therapy, NSCLC Trial (Ensatinib, chemo)

Not yet recruiting
  • ALK Fusion Protein Expression
  • +2 more
  • (no location specified)
Jan 10, 2022

NSCLC Stage IV Trial in New York (Pembrolizumab, Radiation, Chemotherapy)

Recruiting
  • NSCLC Stage IV
  • New York, New York
    NYU Langone Health
Jan 11, 2023

Predicting Biomarker of Gastric Cancer Chemotherapy Response

Recruiting
  • Gastric Cancer
  • +2 more
  • Chemotherapy
  • Daegu, Korea, Republic of
    Kyungpook National University Medical Canter
Aug 8, 2021

Advanced Malignant Tumors Trial in Hangzhou (AK112, AK117, Chemotherapy)

Recruiting
  • Advanced Malignant Tumors
  • Hangzhou, Zhejiang, China
    Zhejiang Cancer Hospital
Jan 27, 2022

Pancreatic Cancer Trial (Chemotherapy, Radiation)

Active, not recruiting
  • Pancreatic Cancer
  • Chemotherapy
  • Radiation
  • (no location specified)
May 30, 2022

Gastric Cancer, Neoadjuvant Chemo Trial in Shanghai (Chemotherapy)

Not yet recruiting
  • Gastric Cancer
  • Neoadjuvant Chemotherapy
  • Chemotherapy
  • Shanghai, Shanghai, China
    Ruijin Hospital Shanghai Jiaotong University School of Medicine
Jul 15, 2021

Chemotherapy-induced Cognitive Alterations in Recruits With

Active, not recruiting
  • Cognition Disorders
  • Polyneuropathies
  • Chemotherapy
  • Berlin, Germany
    Charité Universitätsmedizin Berlin
Aug 13, 2021

Breast Cancer, PI3K, Alpelisib Trial in France (Alpelisib, Chemotherapy)

Active, not recruiting
  • Breast Cancer, PI3K, Alpelisib
  • Angers, France
  • +13 more
Mar 8, 2022

Esophageal Cancer Trial in Hangzhou (Radiotherapy group, Camrelizumab, Chemotherapy)

Not yet recruiting
  • Esophageal Cancer
  • Radiotherapy group
  • +2 more
  • Hangzhou, Zhejiang, China
    Zhejiang Cancer Hospital
Dec 21, 2021

Epithelial Ovarian Cancer Trial in Singapore (Oregovomab, Nivolumab, Chemotherapy)

Unknown status
  • Epithelial Ovarian Cancer
  • Singapore, Singapore
  • +1 more
Nov 30, 2021

Hodgkin Lymphoma, Relapse, Refractory Trial in Chapel Hill (Chemotherapy, Cell infusion)

Not yet recruiting
  • Hodgkin Lymphoma
  • +2 more
  • Chemotherapy
  • Cell infusion
  • Chapel Hill, North Carolina
    Lineberger Comprehensive Cancer Center
Oct 13, 2023

Molecular Analysis and Treatment Options of Thymic Malignancies

Recruiting
  • Thymic Epithelial Tumor
  • +2 more
  • Chemotherapy
  • Shanghai, Shanghai, China
    Xiaomin Niu
Dec 28, 2022

Chemotherapy for Gynecological Malignancy in High-risk Region of

Active, not recruiting
  • Gynecological Cancer
  • Chemotherapy
  • Wuhan, Hubei, China
    Tongji Hospital, Tongji Medical College, Huazhong University of
Oct 6, 2021

Colorectal Cancer, Solid Tumors Trial (SNDX-5613, Chemotherapy)

Not yet recruiting
  • Colorectal Cancer
  • Solid Tumors
  • (no location specified)
Feb 15, 2023

Palliative Primary Tumor Resection in Minimally Symptomatic

Recruiting
  • Colorectal Neoplasms
  • +12 more
  • surgery of the primary tumour
  • chemotherapy
  • Moscow, Russian Federation
    Ryzhikh National Medical Research Center of Coloproctology
Apr 2, 2022

Head Neck Cancer Trial in Houston (drug, other, behavioral)

Active, not recruiting
  • Head and Neck Cancer
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Jan 31, 2022

Invasive Breast Carcinoma, Stage I Breast Cancer AJCC v7, Stage IA Breast Cancer AJCC v7 Trial in United States (drug, other,

Recruiting
  • Invasive Breast Carcinoma
  • +11 more
  • Chemotherapy
  • +4 more
  • Conroe, Texas
  • +4 more
May 3, 2022

NSCLC Trial in United States (Canakinumab, Durvalumab, Radiation therapy)

Recruiting
  • Non-small Cell Lung Cancer
  • Basking Ridge, New Jersey
  • +6 more
Aug 15, 2022